Cadrenal Therapeutics CVKD Income Statement (2022-2026)

NASDAQ CVKD
$1.60 -0.03 (-1.84%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter) 0.02M0.20M0.06M0.35M3.24M0.24M0.24M0.36M0.63M1.25M0.78M1.08M0.71M
Selling, General & Administrative (Quarter) 0.15M0.28M0.92M0.96M0.96M0.78M0.90M0.90M1.13M1.21M1.67M2.66M2.63M
Other Operating Expenses (Quarter) 506.00-2.89M190.00597.00597.00-1.26M597.00470.00407.00401.00504.00
Operating Expenses (Quarter) 0.17M0.48M0.97M-1.59M4.20M1.03M1.14M1.76M2.47M2.46M3.73M3.34M
Operating Income (Quarter) -0.17M-0.48M-0.97M-1.08M-4.20M-1.03M-1.14M-1.26M-1.76M-2.47M-2.46M-3.73M-3.34M
EBIT (Quarter) -0.17M-0.48M-0.97M-1.08M-4.20M-1.03M-1.14M-1.26M-1.76M-2.47M-2.46M-3.73M-3.34M
Non-operating items
Interest & Investment Income (Quarter) 3.001.000.02M0.11M0.12M0.09M0.07M0.05M0.07M0.02M
Other Non Operating Income (Quarter) -0.74M
Non Operating Income (Quarter) -0.02M-0.05M-3.93M-0.97M0.02M0.11M0.12M0.09M0.07M0.05M0.07M0.02M
Net income details
EBT (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.86M-3.33M
Profit After Tax (Quarter) -0.18M-0.50M-1.03M-5.01M-5.17M-1.00M-1.04M-1.14M-1.66M-2.39M-2.41M-3.67M-3.32M
Income from Continuing Operations (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.86M-3.33M
Consolidated Net Income (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.86M-3.33M
Income towards Parent Company (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.86M-3.33M
Net Income towards Common Stockholders (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.67M-3.32M
Additional items
EPS (Basic) (Quarter) -0.35-0.95-1.84-11.92-6.97-2.56-1.73-1.27-1.56-2.25-2.48-1.87-1.14
EPS (Diluted) (Quarter) -0.35-0.95-1.84-2.08-6.97-2.56-1.73-1.27-1.56-2.25-2.48-1.87-1.14
Shares Outstanding (Quarter) 0.50M0.51M0.54M0.09M0.72M0.78M1.03M0.90M1.07M1.07M1.10M1.22M1.84M1.96M2.04M1.99M2.41M2.91M
Shares Outstanding (Diluted) (Quarter) 0.50M0.51M0.54M0.53M0.72M0.78M1.03M0.90M1.07M1.07M1.10M1.22M1.84M1.96M2.04M1.99M2.41M2.91M
Shares Outstanding (Entity) (Quarter) 0.50M0.53M0.54M0.09M0.78M0.78M0.87M0.87M1.07M1.07M1.23M1.22M1.91M2.01M2.06M2.34M2.51M2.91M
EBITDA (Quarter) -0.17M-0.48M-0.97M-1.08M-4.20M-1.03M-1.14M-1.26M-1.76M-2.47M-2.46M-3.73M-3.34M
Interest Expenses (Quarter) 0.00M0.01M0.01M0.02M0.81M1.00M0.74M456.000.01M0.33M4.74M0.89M0.19M0.30M0.30M0.02M0.01M